heme has been researched along with Thrombotic Microangiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amann, K; Bauer, M; Coldewey, SM; Daniel, C; Gunzer, F; Heinemann, SH; Krieg, N; Kröller, S; Mestekemper, AN; Pirschel, W; Tolosano, E; Wissuwa, B | 1 |
| Allain, F; Boulanger, E; Denys, A; Frimat, M; Gibier, JB; Glowacki, F; Gnemmi, V; Grolaux, G; Grunenwald, A; Howsam, M; Laboux, T; Lancel, S; Lebas, C; Lopez, B; Maanaoui, M; Provôt, F; Roumenina, L | 1 |
2 other study(ies) available for heme and Thrombotic Microangiopathies
| Article | Year |
|---|---|
Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice.
Topics: Animals; Disease Progression; Escherichia coli Infections; Haptoglobins; Heme; Hemoglobins; Hemolysis; Hemolytic-Uremic Syndrome; Hemopexin; Mice; Shiga Toxin; Shiga-Toxigenic Escherichia coli; Thrombotic Microangiopathies | 2022 |
Hemolysis is associated with altered heparan sulfate of the endothelial glycocalyx and with local complement activation in thrombotic microangiopathies.
Topics: Atypical Hemolytic Uremic Syndrome; Complement Activation; Complement System Proteins; Endothelial Cells; Glycocalyx; Heme; Hemolysis; Heparitin Sulfate; Humans; Kidney Diseases; Retrospective Studies; Thrombotic Microangiopathies | 2023 |